| Literature DB >> 34968218 |
Joana Pereira Sousa1,2, Hugo Neves3,4, Miguel Pais-Vieira5.
Abstract
Patients with heart failure have difficulty in self-care management, as daily monitoring and recognition of symptoms do not readily trigger an action to avoid hospital admissions. The purpose of this study was to understand the impact of a nurse-led complex intervention on symptom recognition and fluid restriction. A latent growth model was designed to estimate the longitudinal effect of a nursing-led complex intervention on self-care management and quality-of-life changes in patients with heart failure and assessed by a pilot study performed on sixty-three patients (33 control, 30 intervention). Patients in the control group had a higher risk of hospitalisation (IRR 11.36; p < 0.001) and emergency admission (IRR 4.24; p < 0.001) at three-months follow-up. Analysis of the time scores demonstrated that the intervention group had a clear improvement in self-care behaviours (βSlope. Assignment_group = -0.881; p < 0.001) and in the quality of life (βSlope. Assignment_group = 1.739; p < 0.001). This study supports that a nurse-led programme on symptom recognition and fluid restriction can positively impact self-care behaviours and quality of life in patients with heart failure. This randomised controlled trial was retrospectively registered (NCT04892004).Entities:
Keywords: heart failure; nurse-led programme; self-care behaviours; symptom recognition
Year: 2021 PMID: 34968218 PMCID: PMC8608136 DOI: 10.3390/nursrep11020040
Source DB: PubMed Journal: Nurs Rep ISSN: 2039-439X
Figure 1Pilot study RCT CONSORT flowchart.
Figure 2Conditional Latent Growth Curve Model—EHFScBS (European Heart Failure Self-care Behaviour Scale).
Figure 3Conditional Latent Growth Curve Model—QoL (Quality of Life).
Participants’ characteristics.
| Characteristics | Total ( | CG ( | IG ( | Statistic | Effect-Size | |
|---|---|---|---|---|---|---|
| Gender, men (%) | 74.6 | 75.76 | 73.33 | 0.049 a | 0.825 | 0.056 d |
| Male ( | 47 | 25 | 22 | |||
| Female ( | 16 | 8 | 8 | |||
| Age, mean (SD) | 54.83 (10.28) | 54.42 (10.54) | 55.27 (10.15) | 460.0 b | 0.63 | 0.122 e |
| Marital status, with companion (%) | 69.84 | 69.69 | 70 | 0.001 a | 0.979 | 0.008 d |
| NYHA class, III class (%) | 73.02 | 81.81 | 63.33 | 2.725 a | 0.099 | 0.425 d |
| Initial weight, mean (SD) | 78.73 (15.04) | 81.00 (15.56) | 76.23 (14.28) | 1.261 c | 0.212 | 0.318 e |
| EHFScBS, mean (SD) | 38.81 (10.91) | 39.94 (8.27) | 37.57 (13.26) | 454.0 b | 0.572 | 0.143 e |
| QoL, mean (SD) | 67.86 (12.94) | 68.18 (11.78) | 67.50 (14.31) | 0.207 c | 0.837 | 0.052 e |
a Χ2—Pearson’s chi-squared test; b U—Mann–Whitney’s test; c t—Student’s t test; d Φ—phi; e d—Cohen’s d. CG—control group; IG—intervention group; NYHA—New York Heart Association; EHFScBS—European Heart Failure Self-care Behaviour Scale; QoL—quality of life.
Symptom recognition by HF patients.
| CG | IG | Χ2 | Φ | ||
|---|---|---|---|---|---|
| Symptoms and Signs Recognition by Patients | ( | ( | |||
| First-week follow-up | |||||
| Weight increase (>2 kg/3 days or 5 kg/week), yes (%) | 6.06 | 36.67 | 8.988 | 0.003 | 0.378 |
| Oedema, yes (%) | 48.48 | 30 | 2.243 | 0.134 | −0.189 |
| Shortness of breath, yes (%) | 48.48 | 63.33 | 1.403 | 0.236 | 0.149 |
| Fatigue after small effort, yes (%) | 45.45 | 53.33 | 0.39 | 0.532 | 0.079 |
| Sleep seated or with pillows, yes (%) | 3.03 | 16.67 | 3.391 | 0.094 a | 0.232 |
| Daily weight record, yes (%) | 3.03 | 80 | 38.895 | 0 | 0.786 |
| Recognises rapid increase of weight, yes (%) | 0 | 46.67 | 19.8 | 0 | 0.561 |
| Fulfils fluid restriction, yes (%) | 15.15 | 96.67 | 42.032 | 0 | 0.817 |
| Calls doctor or nurse when detects symptoms early, to avoid hospitalisation, yes (%) | 0 | 6.67 | 2.272 b | 0.223 a | 0.19 |
| First-month follow-up | |||||
| Weight increase (>2 kg/3 days or 5 kg/week), yes (%) | 6.06 | 33.33 | 7.58 | 0.006 | 0.347 |
| Oedema, yes (%) | 45.45 | 33.33 | 0.965 | 0.326 | −0.124 |
| Shortness of breath, yes (%) | 54.54 | 76.67 | 3.384 | 0.066 | 0.232 |
| Fatigue after small effort, yes (%) | 48.48 | 60 | 0.839 | 0.36 | 0.115 |
| Sleeps seated or with pillows, yes (%) | 0 | 10 | 3.465 | 0.102 a | 0.235 |
| Daily weight record, yes (%) | 0 | 56.67 | 25.611 | 0 | 0.638 |
| Recognises rapid increase of weight, yes (%) | 0 | 46.67 | 19.8 | 0 | 0.561 |
| Fulfils fluid restriction, yes (%) | 6.06 | 83.33 | 38.314 | 0.000 | 0.78 |
| Calls doctor or nurse when detects symptoms early, to avoid hospitalisation, yes (%) | 3.03 | 20 | 4.582 | 0.047 a | 0.27 |
| Third-month follow-up | |||||
| Weight increase (>2 kg/3 days or 5 kg/week), yes (%) | 0 | 30 | 11.55 | 0.001 a | 0.428 |
| Oedema, yes (%) | 51.51 | 86.67 | 8.961 | 0.003 | 0.377 |
| Shortness of breath, yes (%) | 48.48 | 86.67 | 10.309 | 0.001 | 0.405 |
| Fatigue after small effort, yes (%) | 54.55 | 86.67 | 7.698 | 0.006 | 0.35 |
| Sleeps seated or with pillows, yes (%) | 3.03 | 10 | 1.284 | 0.340 a | 0.143 |
| Daily weight record, yes (%) | 0 | 73.33 | 37.185 | <0.001 | 0.768 |
| Recognises rapid increase of weight, yes (%) | 0 | 60 | 27.72 | <0.001 | 0.663 |
| Fulfils fluid restriction, yes (%) | 6.06 | 90 | 44.569 | <0.001 | 0.841 |
| Calls doctor or nurse when detects symptoms early, to avoid hospitalisation, yes (%) | 15.15 | 40 | 4.925 | 0.026 | 0.28 |
Χ2—Pearson’s chi-squared test; Φ—phi; a Fisher’s exact test p-value; b Fisher’s exact test.
ER and hospital admission during study time.
| ER and Hospital Admissions | Total ( | CG | IG | Statistic | RR (95% CI) * | |
|---|---|---|---|---|---|---|
| First-month follow-up | ||||||
| Resort to the emergency room since last consult, yes (%) | 15.87 | 27.27 | 3.33 | 6.744 b | 0.014 | 8.18 (1.10, 60.82) |
| Hospitalisation, yes (%) | 7.94 | 12.12 | 3.33 | 1.661 b | 0.357 | 3.64 (0.43, 30.45) |
| Three-months follow-up | ||||||
| Resort to the emergency room since last consult, yes (%) | 42.86 | 75.76 | 6.67 | 30.630 b | <0.001 | 11.36 (2.94, 43.96) |
| Hospitalisation, yes (%) | 53.97 | 84.85 | 20.00 | 26.601 a | <0.001 | 4.24 (2.04, 8.80) |
* For control group a Χ2—Pearson’s chi-squared test; b Fisher’s exact test.
Correlation between CG’s QoL and EHFScBS.
| EHFScBS Baseline | EHFScBS | EHFScBS | EHFScBS | ||
|---|---|---|---|---|---|
| QoL baseline | Pearson Correlation | 0.066 | 0.094 | 0.022 | 0.218 |
| 0.714 | 0.603 | 0.905 | 0.223 | ||
|
| 33 | 33 | 33 | 33 | |
| QoL 1 week | Pearson Correlation | 0.024 | −0.035 | 0.029 | 0.058 |
| 0.896 | 0.848 | 0.875 | 0.749 | ||
|
| 33 | 33 | 33 | 33 | |
| QoL 1 month | Pearson Correlation | 0.050 | 0.063 | 0.049 | 0.090 |
| 0.783 | 0.726 | 0.789 | 0.620 | ||
|
| 33 | 33 | 33 | 33 | |
| QoL 3 months | Pearson Correlation | 0.068 | −0.046 | −0.032 | 0.008 |
| 0.707 | 0.798 | 0.859 | 0.965 | ||
|
| 33 | 33 | 33 | 33 | |
Correlation between IG’s QoL and EHFScBS.
| EHFScBS Baseline | EHFScBS | EHFScBS | EHFScBS | ||
|---|---|---|---|---|---|
| QoL baseline | Pearson Correlation | 0.186 | 0.229 | 0.132 | 0.124 |
| 0.326 | 0.224 | 0.487 | 0.514 | ||
|
| 30 | 30 | 30 | 30 | |
| QoL 1 week | Pearson Correlation | 0.030 | −0.171 | −0.138 | −0.145 |
| 0.874 | 0.365 | 0.467 | 0.445 | ||
|
| 30 | 30 | 30 | 30 | |
| QoL 1 month | Pearson Correlation | 0.104 | 0.020 | −0.085 | 0.025 |
| 0.586 | 0.916 | 0.654 | 0.894 | ||
|
| 30 | 30 | 30 | 30 | |
| QoL 3 months | Pearson Correlation | 0.041 | 0.329 | 0.242 | −0.375 * |
| 0.831 | 0.076 | 0.197 | 0.041 | ||
|
| 30 | 30 | 30 | 30 | |
* Correlation is significant at the 0.05 level (2-tailed).